ONCY 주가 차트
ONCY 재무
Oncolytics Biotech Inc.
$0.95
-1.07%
$-0.01
종가: Apr 06, 16:00:00 GMT-4
$0.89
-5.99%
$-0.05
애프터마켓: Apr 06, 20:00:00 GMT-4
뒤로
Oncolytics Biotech Inc. (ONCY) 재무
주요 통계
이전 종가
$0.9603
시가
$0.9459
일일 범위
$0.893 - $0.9856
52주 범위
$0.33 - $1.51
거래량
442.2K
평균 거래량
1.3M
배당수익률
--
EPS(TTM)
-0.30
시가총액
$96.0M
Oncolytics Biotech Inc.란 무엇인가요?
Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. The company is headquartered in Calgary, Alberta. The company went IPO on 2001-10-05. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The company acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype, turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. The firm is also advancing its programs in hormone receptor-positive / human epidermal growth factor 2-negative (HR+/ HER2-) advanced and metastatic breast cancer (mBC) and metastatic pancreatic ductal adenocarcinoma (PDAC) to registration-enabled clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.